Onco Wiki / Disease

T-Lymphoblastic Leukemia / Lymphoma

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

IDDIS-T-ALL
TypeDisease
Aliases
ETP-ALL (subset)T-ALLT-LBLT-Lymphoblastic Leukemia/LymphomaT-лімфобластна лейкемія/лімфома
Statusreviewed 2026-04-25 | pending_clinical_signoff
DiseasesNone declared
SourcesSRC-NCCN-BCELL-2025

Informational support. All recommendations must be verified by a qualified oncologist. Engineering checks are not clinical validation or treatment approval.

Source YAML

icd_o_3_morphology9837/3
icd_10C91.0
who_classificationPrecursor lymphoid neoplasms — T-lymphoblastic leukaemia/lymphoma per WHO 5th ed.

Capabilities

Notes

STUB. Hyper-CVAD-based or pediatric-inspired. CD19 CAR-T NOT applicable (T-cell lineage). Rituximab NOT needed (CD20-). Mediastinal mass — possible airway compromise; emergent steroids/cytoreduction before induction.

Used By

Actionability

Algorithms

Disease

Indication

Questionnaires

Red flag